US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Clinical Trials ETF

44.15

+0.90122.08%

Post-market: 44.13-0.0156-0.04%19:30 EDT

Volume:5K

Turnover:233.98K

Market Cap:41.94M

PE:- -

High:44.42

Open:42.95

Low:42.95

Close:43.24

52wk High:56.18

52wk Low:28.35

Shares:950.00K

Float Shares:950.00K

Volume Ratio:0.30

T/O Rate:0.56%

Dividend:0.65

Dividend Rate:1.48%

ROE:--

ROA:--

PB:0.95

PE(LYR):- -

Loading ...

Overview Company News Filings

Ono Pharma Advances Pediatric Epilepsy Trial, Bolstering Long-Term Growth Story

TRex Bio indicated to open at $14.50, IPO priced at $14

Eli Lilly Quietly Expands Its Alzheimer’s Pipeline With New Early-Stage Trial

Mirum’s AZURE-2 Trial Pits Brelovitug Against Bulevirtide in High-Stakes Hepatitis D Study

Arecor to Present Half-Year Results as It Advances Next-Generation Diabetes Therapies

Hybio Pharmaceutical's HY3003 Injection Clinical Trial Application Accepted by US FDA

BBC should be aggregator of best free sports content – or risk sinking for good

Newron presses on with ENIGMA-TRS program as FDA clinical hold prompts safety review

Apichope Pharmaceutical's Subsidiary Gains FDA Approval for Clinical Trial of Innovative Drug APH04935 Tablets

Trasteel Completes Purchase of Remaining 40% Stake in BBC Alloys

MT Newswires Live

Press Release: Trasteel Holding S.A. Completes Acquisition of the Remaining 40% Interest in BBC Alloys S.r.l.

Mirum Advances MRM-3379 With Completed Phase 1 ADME Study

Former Gilead and Amgen Commercial Leader Laura Hamill Just Joined Entera (NASDAQ: ENTX)

ArriVent says Phase 3 firmonertinib trial did not meet endpoint

Kairos Pharma announces interim efficacy data from Phase 2 trial of ENV-105

BNK Banking Sets Virtual Date for 2026 Annual General Meeting

Vaxcyte data hit ‘blue-sky’ case, says Jefferies

10 Monday AM Reads

The Big Picture

Vaxcyte announces ‘positive’ results from OPUS-1 Phase 3 trial of VAX-31

Alterity’s ATH434 Phase 2 Data Strengthen Case for MSA Phase 3 Trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/BBC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBC\",,,,,undefined,":{"symbol":"BBC","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Clinical Trials ETF","latestPrice":44.1456,"timestamp":1791576000000,"preClose":43.2444,"halted":0,"volume":5323,"hourTrading":{"tag":"盘后","latestPrice":44.13,"preClose":44.1456,"latestTime":"19:30 EDT","volume":7,"amount":309.1736,"timestamp":1791588604414,"change":-0.0156,"changeRate":-0.000353,"amplitude":0},"delay":0,"changeRate":0.02083969253822467,"floatShares":950000,"shares":950000,"eps":0,"marketStatus":"Market Closed","change":0.9012,"latestTime":"10-09 16:00:00 EDT","open":42.95,"high":44.42,"low":42.95,"amount":233977.915752,"amplitude":0.033993,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":43.2444,"sharesOutstanding":900004,"nav":43.154,"aum":40996484.05,"dividendRate":0.014796,"bidAskSpread":0.002156,"postHourTrading":{"tag":"盘后","latestPrice":44.13,"preClose":44.1456,"latestTime":"19:30 EDT","volume":7,"amount":309.1736,"timestamp":1791588604414,"change":-0.0156,"changeRate":-0.000353,"amplitude":0},"volumeRatio":0.30431402299296023,"impliedVol":0.3343,"impliedVolPercentile":0.5259},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBC\",,,,,undefined,":{"symbol":"BBC","floatShares":950000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.30431402299296023,"shares":950000,"dividePrice":0.6532,"high":44.42,"amplitude":0.033993,"preClose":43.2444,"low":42.95,"week52Low":28.3519,"pbRate":"0.95","week52High":56.18,"institutionHeld":0,"latestPrice":44.1456,"eps":0,"divideRate":0.014796,"volume":5323,"delay":0,"ttmEps":0,"open":42.95,"prevYearClose":38.56,"prevWeekClose":44.5638,"prevMonthClose":46.2948,"prevQuarterClose":46.2948,"fiveDayClose":44.5638,"twentyDayClose":49.3848,"sixtyDayClose":49.911},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBC\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBC","amount":0.65544,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-29","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-29"},{"date":"2024-12-20","symbol":"BBC","amount":0.23947,"announcedDate":"2024-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-20","defaultRemindTime":1734705000000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-27","payableDate":"2024-12-20","currency":"USD","dateTimestamp":1734670800000,"payDate":"2024-12-27"},{"date":"2023-12-20","symbol":"BBC","amount":0.0823,"announcedDate":"2023-12-19","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","recordDate":"2023-12-29","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBC\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-29","value":0.0823,"currency":"USD"},{"executeDate":"2024-12-20","recordDate":"2024-12-20","paymentDate":"2024-12-27","value":0.23947,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-29","value":0.65544,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2674865909","title":"Ono Pharma Advances Pediatric Epilepsy Trial, Bolstering Long-Term Growth Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2674865909","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674865909?lang=en_us&edition=fundamental","pubTime":"2026-10-10 00:31","pubTimestamp":1791563500,"startTime":"0","endTime":"0","summary":"ONO Pharmaceutical Co ($OPHLF) announced an update on their ongoing clinical study. Ono Pharmaceutical Co., Ltd. (OPHLF) is running a Phase 3 trial...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ono-pharma-advances-pediatric-epilepsy-trial-bolstering-long-term-growth-story?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ono-pharma-advances-pediatric-epilepsy-trial-bolstering-long-term-growth-story?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","OPHLF","BBC","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674686768","title":"TRex Bio indicated to open at $14.50, IPO priced at $14","url":"https://stock-news.laohu8.com/highlight/detail?id=2674686768","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674686768?lang=en_us&edition=fundamental","pubTime":"2026-10-09 22:45","pubTimestamp":1791557133,"startTime":"0","endTime":"0","summary":"TRex Bio (TRXB), a clinical-stage biotechnology company focused on tissue Treg biology for the discovery and development of immunoregulatory medici...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/trex-bio-indicated-to-open-at-14-50-ipo-priced-at-14-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/trex-bio-indicated-to-open-at-14-50-ipo-priced-at-14-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4127","BBP","FHLC","TRXB","BK4588","FWD","IEIH","REDS","FRHC","IPOS","LNGR","BK4585","RSPH","BBC","KCE","JDOC","DARP","SYNB","IBB","XT","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674009726","title":"Eli Lilly Quietly Expands Its Alzheimer’s Pipeline With New Early-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2674009726","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674009726?lang=en_us&edition=fundamental","pubTime":"2026-10-09 00:32","pubTimestamp":1791477137,"startTime":"0","endTime":"0","summary":"Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. Eli Lilly & Co.’s new Phase 1 trial, “A Placebo-Controlled, Singl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eli-lilly-quietly-expands-its-alzheimers-pipeline-with-new-early-stage-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eli-lilly-quietly-expands-its-alzheimers-pipeline-with-new-early-stage-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674090940","title":"Mirum’s AZURE-2 Trial Pits Brelovitug Against Bulevirtide in High-Stakes Hepatitis D Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2674090940","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674090940?lang=en_us&edition=fundamental","pubTime":"2026-10-09 00:31","pubTimestamp":1791477107,"startTime":"0","endTime":"0","summary":"Mirum Pharmaceuticals ($MIRM) announced an update on their ongoing clinical study. The AZURE-2 Phase 3 trial from Mirum Pharmaceuticals, Inc. tests...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mirums-azure-2-trial-pits-brelovitug-against-bulevirtide-in-high-stakes-hepatitis-d-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mirums-azure-2-trial-pits-brelovitug-against-bulevirtide-in-high-stakes-hepatitis-d-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673072167","title":"Arecor to Present Half-Year Results as It Advances Next-Generation Diabetes Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2673072167","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673072167?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:04","pubTimestamp":1791461092,"startTime":"0","endTime":"0","summary":"Arecor Therapeutics PLC ( ($GB:AREC) ) has provided an announcement. Arecor Therapeutics plc, a Cambridge-based clinical-stage biotech, is developi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arecor-to-present-half-year-results-as-it-advances-next-generation-diabetes-therapies?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arecor-to-present-half-year-results-as-it-advances-next-generation-diabetes-therapies?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBIX","NVIB","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158212836","title":"Hybio Pharmaceutical's HY3003 Injection Clinical Trial Application Accepted by US FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=1158212836","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158212836?lang=en_us&edition=fundamental","pubTime":"2026-10-08 16:36","pubTimestamp":1791448575,"startTime":"0","endTime":"0","summary":"Hybio Pharmaceutical Co.,Ltd. (300199.SZ) has announced that the company recently received a clinical trial application acceptance notice from the US Food and Drug Administration (FDA) regarding...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0070","BK0239","BBC","BK0028","BK0188","300199","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673187025","title":"BBC should be aggregator of best free sports content – or risk sinking for good","url":"https://stock-news.laohu8.com/highlight/detail?id=2673187025","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673187025?lang=en_us&edition=fundamental","pubTime":"2026-10-08 14:00","pubTimestamp":1791439200,"startTime":"0","endTime":"0","summary":"Eyes on the BBC, then, no longer home to England football but still with an opportunity to reclaim a piece of the sport-loving nation’s heart.Our public broadcaster’s response?Wales v Denmark in the Nations League, prime time evening slot on BBC2. Tick. SWPL afternoon football on the BBC Sport app. Tick. But otherwise the only ‘live’ sport I could find on its platforms was Major League Baseball – the Braves at the Dodgers in the first of their National League Division Series games.Stay ahead with our three daily briefings delivering all the key market moves, top business and political stories, and incisive analysis straight to your inbox.‘Live’ in inverted commas because the billing on iPlayer that afternoon actually referred to a contest that had taken place the night before in LA. Seeing the score at 0-2 to the Dodgers in the fifth, I couldn’t resist the temptation to check out the final result. And so curiosity killed my ‘live’ experience. .Angered by the BBC’s dwindling interest in","market":"us","thumbnail":"https://www.cityam.com/wp-content/uploads/2026/10/GettyImages-2206507927-1-e1791409651519.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2026/10/GettyImages-2206507927-1-e1791409651519.jpg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/bbc-should-be-aggregator-of-best-free-sports-content-or-risk-sinking-for-good/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/bbc-should-be-aggregator-of-best-free-sports-content-or-risk-sinking-for-good/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673023384","title":"Newron presses on with ENIGMA-TRS program as FDA clinical hold prompts safety review","url":"https://stock-news.laohu8.com/highlight/detail?id=2673023384","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673023384?lang=en_us&edition=fundamental","pubTime":"2026-10-08 13:32","pubTimestamp":1791437568,"startTime":"0","endTime":"0","summary":"An announcement from Newron Pharmaceuticals SpA ( ($CH:NWRN) ) is now available. Newron Pharmaceuticals has received a formal notification from the...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/newron-presses-on-with-enigma-trs-program-as-fda-clinical-hold-prompts-safety-review?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/newron-presses-on-with-enigma-trs-program-as-fda-clinical-hold-prompts-safety-review?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","BK4588","MEDX","BK4585","PTH","IBB","BBC","BIS","IBBQ","PILL","PSCH","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196824649","title":"Apichope Pharmaceutical's Subsidiary Gains FDA Approval for Clinical Trial of Innovative Drug APH04935 Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=1196824649","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196824649?lang=en_us&edition=fundamental","pubTime":"2026-10-08 11:54","pubTimestamp":1791431652,"startTime":"0","endTime":"0","summary":"Apichope Pharmaceutical Group Co.,Ltd. (300723.SZ) has announced that its wholly-owned subsidiary, Guangzhou Apichope Pharmaceutical Co., Ltd. (\"Apichope Pharma\"), recently received a letter from the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","BBC","LNGR","BK1574","300723","IBBQ","BK1161","BK0239","159992","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673004390","title":"Trasteel Completes Purchase of Remaining 40% Stake in BBC Alloys","url":"https://stock-news.laohu8.com/highlight/detail?id=2673004390","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673004390?lang=en_us&edition=fundamental","pubTime":"2026-10-08 05:47","pubTimestamp":1791409627,"startTime":"0","endTime":"0","summary":"Trasteel Holding's international unit completed the acquisition of the remaining 40% interest in BBC Alloys from Metco for about 1.7 million euros .Trasteel said Wednesday its business combination with Sizzle Acquisition Corp. II  is expected to close by year end, with the combined company slated to list on Nasdaq under the ticker TSTL.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SZZLU","SZZL","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673101280","title":"Press Release: Trasteel Holding S.A. Completes Acquisition of the Remaining 40% Interest in BBC Alloys S.r.l.","url":"https://stock-news.laohu8.com/highlight/detail?id=2673101280","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673101280?lang=en_us&edition=fundamental","pubTime":"2026-10-08 04:05","pubTimestamp":1791403500,"startTime":"0","endTime":"0","summary":"LUGANO, Switzerland and BERTRANGE, Luxembourg, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Trasteel Holding S.A. (\"Trasteel\" or the \"Company\"), a global steel trading and industrial group (the \"Group\") headquar","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SZZL","BBC","CEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673011746","title":"Mirum Advances MRM-3379 With Completed Phase 1 ADME Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2673011746","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673011746?lang=en_us&edition=fundamental","pubTime":"2026-10-08 00:30","pubTimestamp":1791390610,"startTime":"0","endTime":"0","summary":"Mirum Pharmaceuticals ($MIRM) announced an update on their ongoing clinical study. Mirum Pharmaceuticals, Inc. is running a Phase 1 trial called “A...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mirum-advances-mrm-3379-with-completed-phase-1-adme-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mirum-advances-mrm-3379-with-completed-phase-1-adme-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","MRM","ADME","BK4192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673656016","title":"Former Gilead and Amgen Commercial Leader Laura Hamill Just Joined Entera (NASDAQ: ENTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673656016","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673656016?lang=en_us&edition=fundamental","pubTime":"2026-10-07 22:00","pubTimestamp":1791381622,"startTime":"0","endTime":"0","summary":"WSW, NY, October 7th, 2026, FinanceWire The former Gilead and Amgen commercial leader takes her seat as Entera’s Phase 3 trial nears its init...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/former-gilead-and-amgen-commercial-leader-laura-hamill-just-joined-entera-nasdaq-entx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/former-gilead-and-amgen-commercial-leader-laura-hamill-just-joined-entera-nasdaq-entx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","IBB","NQmain","MNQmain","BK4566","QDTE","QLD","BK4599","03086","BBC","LU0320765992.SGD","QQQM","TQQQ","ONEQ","JEPQ","TBXU","LU0889565916.HKD","QID","SQQQ","IE0002141913.USD","PBE","BK4534","IE00BJT1NW94.SGD","GPIQ","IE0009355771.USD","BK4139","LU1983299246.USD","LU1057294990.SGD","QQQE","AMGN","PJP","QQQJ","TECS","LU0122379950.USD","PSQ","BIB","NDX","IE00BFTCPJ56.SGD","FTEC","IYW","NVIW.SI","QYLG","BBH","QQQ","QQQA",".IXIC","QQQY","IBBQ","ENTX","TQQY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673051961","title":"ArriVent says Phase 3 firmonertinib trial did not meet endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2673051961","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673051961?lang=en_us&edition=fundamental","pubTime":"2026-10-06 21:13","pubTimestamp":1791292413,"startTime":"0","endTime":"0","summary":"ArriVent BioPharma (AVBP) announced that the FURVENT Phase 3 trial evaluating firmonertinib monotherapy in patients with previously untreated, loca...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/arrivent-says-phase-3-firmonertinib-trial-did-not-meet-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/arrivent-says-phase-3-firmonertinib-trial-did-not-meet-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BBC","PSIL","AVBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673705514","title":"Kairos Pharma announces interim efficacy data from Phase 2 trial of ENV-105","url":"https://stock-news.laohu8.com/highlight/detail?id=2673705514","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673705514?lang=en_us&edition=fundamental","pubTime":"2026-10-06 19:35","pubTimestamp":1791286532,"startTime":"0","endTime":"0","summary":"Kairos Pharma (KAPA) announced positive interim efficacy data from its ongoing Phase 2 clinical trial evaluating ENV-105 in combination with apalut...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kairos-pharma-announces-interim-efficacy-data-from-phase-2-trial-of-env-105-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kairos-pharma-announces-interim-efficacy-data-from-phase-2-trial-of-env-105-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KAIR","BK4139","NVIB","HYLG","BBC","PSIL","GDOC","MEDX","IDNA","KAPA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673080367","title":"BNK Banking Sets Virtual Date for 2026 Annual General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2673080367","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673080367?lang=en_us&edition=fundamental","pubTime":"2026-10-06 07:57","pubTimestamp":1791244657,"startTime":"0","endTime":"0","summary":"An update from BNK Banking Corporation Limited ( ($AU:BBC) ) is now available. BNK Banking Corporation Limited has announced that its 2026 Annual G...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bnk-banking-sets-virtual-date-for-2026-annual-general-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bnk-banking-sets-virtual-date-for-2026-annual-general-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673088978","title":"Vaxcyte data hit ‘blue-sky’ case, says Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2673088978","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673088978?lang=en_us&edition=fundamental","pubTime":"2026-10-05 21:55","pubTimestamp":1791208523,"startTime":"0","endTime":"0","summary":"After Vaxcyte (PCVX) announced topline results from the OPUS-1 pivotal adult Phase 3 trial evaluating its VAX-31 31-valent pneumococcal conjugate v...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vaxcyte-data-hit-blue-sky-case-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vaxcyte-data-hit-blue-sky-case-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","PCVX","PSIL","LU0053671581.USD","IE0009354923.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673707819","title":"10 Monday AM Reads","url":"https://stock-news.laohu8.com/highlight/detail?id=2673707819","media":"The Big Picture","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673707819?lang=en_us&edition=fundamental","pubTime":"2026-10-05 18:30","pubTimestamp":1791196218,"startTime":"0","endTime":"0","summary":"Private Equity Has a Problem. Uncle Sam Says Your Wallet Can Fix It.: A government proposal would help fund managers sell alternative investments to a much wider audience. Wall Street’s problem becomes Main Street’s opportunity, or vice versa.‘Things may get ugly’: Meta’s new AI Muse is about to make the internet more annoying: Thomas Germain: the web was built for humans, and Meta’s agent is about to start using it on their behalf. Someday we’ll redesign the internet for tools like this. Until then, you’re in for a wild ride.  see also Meta open sources code to let you make Muse AI gadgets: Meta now lets you connect Muse to your own hardware to put on your displays or a Raspberry Pi.Jay Peters: Meta now lets anyone build hardware around its Muse agent, suggesting projects like an E Ink reminder display. . Paint it black: Efficacy of increased wind turbine rotor blade visibility to reduce avian fatalities,.Painting one of the blades of","market":"us","thumbnail":"https://ritholtz.com/wp-content/uploads/2030/07/vix.png","type":0,"news_type":0,"thumbnails":["https://ritholtz.com/wp-content/uploads/2030/07/vix.png"],"rights":{"source":"ritholtz_highlight","url":"https://ritholtz.com/2026/10/10-monday-am-reads-495/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://ritholtz.com/2026/10/10-monday-am-reads-495/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"ritholtz_highlight","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673709724","title":"Vaxcyte announces ‘positive’ results from OPUS-1 Phase 3 trial of VAX-31","url":"https://stock-news.laohu8.com/highlight/detail?id=2673709724","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673709724?lang=en_us&edition=fundamental","pubTime":"2026-10-05 18:10","pubTimestamp":1791195037,"startTime":"0","endTime":"0","summary":"Vaxcyte (PCVX) announced positive topline results from the OPUS-1 pivotal adult Phase 3 trial evaluating the safety, tolerability and immunogenicit...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vaxcyte-announces-positive-results-from-opus-1-phase-3-trial-of-vax-31-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vaxcyte-announces-positive-results-from-opus-1-phase-3-trial-of-vax-31-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PSIL","PCVX","BBC","IE0009354923.USD","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673776067","title":"Alterity’s ATH434 Phase 2 Data Strengthen Case for MSA Phase 3 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2673776067","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673776067?lang=en_us&edition=fundamental","pubTime":"2026-10-05 07:22","pubTimestamp":1791156146,"startTime":"0","endTime":"0","summary":"An announcement from Alterity Therapeutics ( ($AU:ATH) ) is now available. Alterity Therapeutics reported new analyses from its Phase 2 trial of AT...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alteritys-ath434-phase-2-data-strengthen-case-for-msa-phase-3-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alteritys-ath434-phase-2-data-strengthen-case-for-msa-phase-3-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","BBC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":1,"totalSize":177,"code":"91000000","status":"200"}]}}